Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alterity Therapeutics (ATHE) Other Non-Current Liabilities (2017 - 2024)

Alterity Therapeutics has reported Other Non-Current Liabilities over the past 3 years, most recently at $24499.7 for Q2 2019.

  • For Q2 2019, Other Non-Current Liabilities rose 3433.04% year-over-year to $24499.7; the TTM value through Jun 2019 reached $24499.7, up 3433.04%, while the annual FY2019 figure was $24499.7, 3433.04% up from the prior year.
  • Other Non-Current Liabilities for Q2 2019 was $24499.7 at Alterity Therapeutics, up from $693.45 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $24499.7 in Q2 2019 and troughed at $330.53 in Q2 2017.
  • A 3-year average of $8507.9 and a median of $693.45 in 2018 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 109.8% in 2018 and later skyrocketed 3433.04% in 2019.
  • Year by year, Other Non-Current Liabilities stood at $330.53 in 2017, then soared by 109.8% to $693.45 in 2018, then skyrocketed by 3433.04% to $24499.7 in 2019.
  • Business Quant data shows Other Non-Current Liabilities for ATHE at $24499.7 in Q2 2019, $693.45 in Q2 2018, and $330.53 in Q2 2017.